Addex Therapeutics Ltd
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	CHF2.91M N/A	CHF1.42M -51.22%	CHF1.61M 13.39%	Avg: CHF750K Low: CHF562.5K High: CHF937.5K avg. -53.50%	Avg: CHF750K Low: CHF562.5K High: CHF937.5K avg. 0%	Avg: CHF7M Low: CHF5.25M High: CHF8.75M avg. 833.33%
Net Income % change YoY	CHF-15.41M N/A	CHF-21.06M -36.67%	CHF-10.55M 49.89%	Avg: CHF-1.85M Low: CHF-2.46M High: CHF-1.25M avg. 82.40%	Avg: CHF-1.48M Low: CHF-1.96M High: CHF-1.00M avg. 20%	Avg: CHF0 Low: CHF0 High: CHF0 avg. 100%
EBITDA % change YoY	CHF-15.15M N/A	CHF-20.16M -33.09%	CHF-10.22M 49.28%	Avg: CHF-750K Low: CHF-937.5K High: CHF-562.5K avg. 92.66%	Avg: CHF-750K Low: CHF-937.5K High: CHF-562.5K avg. 0%	Avg: CHF-7M Low: CHF-8.75M High: CHF-5.25M avg. -833.33%
EPS % change YoY	-$0.45 N/A	-$0.47 -4.44%	-$0.14 70.21%	Avg: -$0.03 Low: -$0.03 High: -$0.02 avg. 82.14%	Avg: -$0.02 Low: -$0.03 High: -$0.01 avg. 20.00%	Avg: $0 Low: $0 High: $0 avg. 100%
Operating Expenses % change YoY	CHF18.42M N/A	CHF21.94M 19.10%	CHF11.89M -45.79%	Avg: CHF1.93M Low: CHF1.44M High: CHF2.41M avg. -83.77%	Avg: CHF1.93M Low: CHF1.44M High: CHF2.41M avg. 0%	Avg: CHF18.01M Low: CHF13.51M High: CHF22.52M avg. 833.33%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 34.13% in 2025-2027.

We have gathered data from 2 analysts. Their low estimate is -2.46M, average is -1.85M and high is -1.25M.

Wall Street analysts forecast annual average revenue growth of 259.94% in 2025-2027.

We have gathered data from 2 analysts. Their low revenue estimate is CHF562.5K, average is CHF750K and high is CHF937.5K.

Wall Street analysts forecast annual average earnings growth of 34.04% in 2025-2027.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.03, average is -$0.03 and high is CHF-0.01.